Bone mesenchymal stem cells contributed to the neointimal formation after arterial injury

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Li, Mincai ^a   Li, Suqin ^a   Yu, Liangzhu ^a   Wu, Jiliang ^a   She, Tonghui ^a   Gan, Yaping ^a   Hu, Zhenwu ^a   Liao, Wenli ^a   Xia, Hongli ^b  

^a HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Central Hospital of Xianning   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LESION; ARTICLE; CAROTID ARTERY INJURY; CELL DIFFERENTIATION; CELL MIGRATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; ICAM 1 GENE; IN VIVO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEOINTIMA; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VCAM 1 GENE;

ANIMALS; ARTERIES; BIOLOGICAL MARKERS; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; IMMUNOPHENOTYPING; INTERCELLULAR ADHESION MOLECULE-1; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; NEOINTIMA; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; RNA, MESSENGER; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR SYSTEM INJURIES;

EID: 84891950725     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082743     Document Type: Article

References (39)

1. Sata M (2003) Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 13: 249-253. doi:10.1016/S1050-1738(03)00106-3. PubMed: 12922022. (Pubitemid 36960173)
2. Hegner B, Weber M, Dragun D, Schulze-Lohoff E (2005) Differential regulation of smooth muscle markers in human bone marrow-derived mesenchymal stem cells. J Hypertens 23: 1191-1202. doi: 10.1097/01.hjh.0000170382.31085.5d. PubMed: 15894895. (Pubitemid 40862723)
3. Hristov M, Zernecke A, Schober A, Weber C (2008) Adult progenitor cells in vascular remodeling during atherosclerosis. Biol Chem 389: 837-844. PubMed: 18627306.
4. Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M et al. (2003) Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108: 3115-3121. doi:10.1161/01.CIR.0000106906.56972.83. PubMed: 14676142. (Pubitemid 38031801)
5. Briasoulis A, Tousoulis D, Antoniades C, Stefanadis C, Papageorgiou N (2010) The Role of Endothelial Progenitor Cells in Vascular Repair after Arterial Injury and Atherosclerotic Plaque Development. Cardiovasc. Ther.
6. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A et al. (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913-1918. doi:10.1161/01.CIR.0000034046.87607.1C. PubMed: 12370212. (Pubitemid 35176294)
7. Leistner DM, Fischer-Rasokat U, Honold J, Seeger FH, Schächinger V et al. (2011) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5- year results suggest long-term safety and efficacy. Clin Res Cardiol 100: 925-934. doi:10.1007/s00392-011-0327-y. PubMed: 21633921.
8. Fischer-Rasokat U, Assmus B, Seeger FH, Honold J, Leistner D et al. (2009) A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail 2: 417-423. doi:10.1161/ CIRCHEARTFAILURE.109.855023. PubMed: 19808371.
9. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P et al. (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141-148. doi:10.1016/S0140-6736(04)16626-9. PubMed: 15246726. (Pubitemid 38891685)
10. Meyer GP, Wollert KC, Lotz J, Pirr J, Rager U et al. (2009) Intracoronary bone marrow cell transfer after myocardial infarction: 5- year follow-up from the randomized-controlled BOOST trial. Eur Heart J 30: 2978-2984. doi:10.1093/eurheartj/ehp374. PubMed: 19773226.
11. Real C, Caiado F, Dias S (2008) Endothelial progenitors in vascular repair and angiogenesis: how many are needed and what to do? Cardiovasc Hematol Disord Drug Targets 8: 185-193. doi: 10.2174/187152908785849071. PubMed: 18781931.
12. Kim HJ, Kim UJ, Vunjak-Novakovic G, Min BH, Kaplan DL (2005) Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells. Biomaterials 26: 4442-4452. doi:10.1016/j.biomaterials.2004.11.013. PubMed: 15701373. (Pubitemid 40208605)
13. Eggermann J, Kliche S, Jarmy G, Hoffmann K, Mayr-Beyrle U et al. (2003) Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res 58: 478-486. doi:10.1016/S0008-6363(03)00252-9. PubMed: 12757882. (Pubitemid 36570406)
14. Hoffmann B, Beer M, Schelp C, Schirrmeier H, Depner K (2005) Validation of a real-time RT-PCR assay for sensitive and specific detection of classical swine fever. J Virol Methods 130: 36-44. doi: 10.1016/j.jviromet.2005.05.030. PubMed: 16055202. (Pubitemid 41596982)
15. Deng W, Bivalacqua TJ, Chattergoon NN, Jeter JR Jr., Kadowitz PJ (2004) Engineering ex vivo-expanded marrow stromal cells to secrete calcitonin gene-related peptide using adenoviral vector. Stem Cells 22: 1279-1291. doi:10.1634/stemcells.2004-0032. PubMed: 15579646. (Pubitemid 39636404)
16. Houwerzijl EJ, Blom NR, van der Want JJ, Esselink MT, Koornstra JJ et al. (2004) Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood 103: 500-506. doi:10.1182/blood-2003-01-0275. PubMed: 12969975. (Pubitemid 38140080)
17. Pawelczyk E, Arbab AS, Chaudhry A, Balakumaran A, Robey PG et al. (2008) In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Stem Cells 26: 1366-1375. doi:10.1634/stemcells. 2007-0707. PubMed: 18276802.
18. Hutter R, Carrick FE, Valdiviezo C, Wolinsky C, Rudge JS et al. (2004) Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 110: 2430-2435. doi:10.1161/01.CIR.0000145120.37891.8A. PubMed:15477421. (Pubitemid 39407350)
19. Méhes G, Witt A, Kubista E, Ambros PF (2001) Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159: 17-20. doi: 10.1016/S0002-9440(10)61667-7. PubMed: 11438448. (Pubitemid 33704186)
20. Dejana E, Corada M, Lampugnani MG (1995) Endothelial cell-to-cell junctions. FASEB J 9: 910-918. PubMed: 7615160.
21. Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O et al. (1995) The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol 129: 203-217. doi:10.1083/jcb.129.1.203. PubMed: 7698986.
22. Lawson C, Wolf S (2009) ICAM-1 signaling in endothelial cells. Pharmacol Rep 61: 22-32. PubMed: 19307690.
23. Jackson DE, Gully LM, Henshall TL, Mardell CE, Macardle PJ (2000) Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) is associated with a naive B-cell phenotype in human tonsils. Tissue Antigens 56: 105-116. doi:10.1034/j.1399-0039.2000.560201.x. PubMed: 11019910. (Pubitemid 30621276)
24. Kroll H, Sun QH, Santoso S (2000) Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia. Blood 96: 1409-1414. PubMed: 10942385. (Pubitemid 30658471)
25. Galbusera M, Zoja C, Donadelli R, Paris S, Morigi M et al. (1997) Fluid shear stress modulates von Willebrand factor release from human vascular endothelium. Blood 90: 1558-1564. PubMed: 9269774. (Pubitemid 27355428)
26. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R et al. (2002) Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106: 3009-3017. Available online at: doi:10.1161/01.CIR. 0000043246.74879.CD. PubMed: 12473544. (Pubitemid 35440281)
27. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV et al. (2006) Cytokinemediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12: 557-567. doi: 10.1038/nm1400. PubMed: 16648859.
28. Petit I, Jin D, Rafii S (2007) The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 28: 299-307. doi:10.1016/j.it.2007.05.007. PubMed: 17560169. (Pubitemid 46963141)
29. Li Y, Yu J, Li M, Qu Z, Ruan Q (2011) Mouse mesenchymal stem cells from bone marrow differentiate into smooth muscle cells by induction of plaque-derived smooth muscle cells. Life Sci 88: 130-140. doi:10.1016/j.lfs. 2010.10.030. PubMed: 21094172.
30. Li M, Yu J, Li Y, Li D, Yan D et al. (2010) CXCR4 positive bone mesenchymal stem cells migrate to human endothelial cell stimulated by ox-LDL via SDF-1α/CXCR4 signaling axis. Exp Mol Pathol 88: 250-255. doi:10.1016/j.yexmp.2009.12.001. PubMed: 20025867.
31. Li M, Yu J, Li Y, Li D, Yan D, et al. (2010) CXCR4+ progenitors derived from bone mesenchymal stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Cellular Reprogramming (Formerly" Cloning and Stem Cells") 12: 405-415
32. Chen SL, Fang WW, Ye F, Liu YH, Qian J et al. (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94: 92-95. doi:10.1016/j.amjcard.2004.03.034. PubMed: 15219514. (Pubitemid 38813459)
33. Gulati R, Jevremovic D, Peterson TE, Witt TA, Kleppe LS et al. (2003) Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 108: 1520-1526. doi: 10.1161/01.CIR.0000089084. 48655.49. PubMed: 12952850. (Pubitemid 37176461)
34. Novotny NM, Markel TA, Crisostomo PR, Meldrum DR (2008) Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: role of NFkB. Cytokine 43: 215-219. doi: 10.1016/j.cyto.2008.05.015. PubMed: 18621544.
35. Ionescu L, Byrne RN, van Haaften T, Vadivel A, Alphonse RS et al. (2012) Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol 303: L967-L977. doi:10.1152/ajplung.00144.2011. PubMed: 23023971.
36. Li H, Zuo S, He Z, Yang Y, Pasha Z et al. (2010) Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival. Am J Physiol Heart Circ Physiol 299: H1772-H1781. doi:10.1152/ajpheart.00557.2010. PubMed: 20870802.
37. Uemura R, Xu M, Ahmad N, Ashraf M (2006) Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98: 1414-1421. doi:10.1161/01.RES. 0000225952.61196.39. PubMed: 16690882. (Pubitemid 43948066)
38. Zacharaki D, Lagoudaki R, Touloumi O, Kotta K, Voultsiadou A et al. (2013) Characterization of In Vitro Expanded Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Experimental Autoimmune Encephalomyelitis Mice. J Mol Neurosci, 51: 282-97. PubMed: 23532769.
39. Wakitani S, Okabe T, Horibe S, Mitsuoka T, Saito M et al. (2011) Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med 5: 146-150. doi:10.1002/term.299. PubMed: 20603892.